Clinical Trial Update: Treating Heart Failure With hPSC-CMs [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) for the treatment of heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• hPSC-CMs (human pluripotent stem cell-derived cardiomyocytes)

Snippet

Sponsor: HELP Therapeutics Co., Ltd. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED